Browse by People

Collapse authors list.
Poh, Xuan Ying, Tan, Chee Wah, Lee, I Russel, Chavatte, Jean-Marc, Fong, Siew-Wai, Prince, Tessa ORCID: 0000-0002-8796-2629, Hartley, Catherine, Yeoh, Aileen Ying-Yan, Rao, Suma, Chia, Po Ying et al (show 16 more authors) , Ong, Sean WX, Lee, Tau Hong, Sadarangani, Sapna P, Lin, Ray JH, Lim, Clarissa, Teo, Jefanie, Lim, Daniel RX, Chia, Wanni, Hiscox, Julian A ORCID: 0000-0002-6582-0275, Ng, Lisa FP ORCID: 0000-0003-4071-5222, Ren, Ee Chee, Lin, Raymond TP, Renia, Laurent, Lye, David Chien, Wang, Lin-Fa and Young, Barnaby E (2022) Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial. Clinical Infectious Diseases, 75 (12). pp. 2088-2096.

Collapse authors list.
Rouers, Angeline, Wong, Nathan, Goh, Yun Shan, Torres-Ruesta, Anthony, Tay, Matthew Zirui, Chang, Zi Wei, Fong, Siew-Wai, Neo, Vanessa, Kam, Isaac Kai Jie, Yeo, Nicholas Kim-Wah et al (show 24 more authors) , Huang, Yuling, Loh, Chiew Yee, Hor, Pei Xiang, Wong, Joel Xu En, Tan, Yong Jie, Macary, Paul A, Qian, Xinlei, Bei, Wang, Ngoh, Eve Zi Xian, Salleh, Siti Nazihah Mohd, Wang, Cheng-I, Poh, Xuan Ying, Rao, Suma, Chia, Po Ying, Ong, Sean WX, Lee, Tau Hong, Lin, Ray JH, Lim, Clarissa, Teo, Jefanie, Ren, Ee Chee, Lye, David Chien, Young, Barnaby E, Ng, Lisa FP ORCID: 0000-0003-4071-5222 and Renia, Laurent (2023) Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters. JOURNAL OF MEDICAL VIROLOGY, 95 (1). e28258-.

Collapse authors list.
Poh, Xuan Ying, Lee, I Russel, Lim, Clarissa, Teo, Jefanie, Rao, Suma, Chia, Po Ying, Ong, Sean WX, Lee, Tau Hong, Lin, Ray JH, Ng, Lisa FP ORCID: 0000-0003-4071-5222 et al (show 6 more authors) , Ren, Ee Chee, Lin, Raymond TP, Wang, Lin-Fa, Renia, Laurent, Lye, David Chien and Young, Barnaby E (2022) Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]. TRIALS, 23 (1). 498-.